Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

James Suen

Concepts (317)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Arteriovenous Malformations
9
2018
75
1.450
Why?
Head and Neck Neoplasms
14
2012
291
1.220
Why?
Carcinoma, Squamous Cell
12
2011
332
0.830
Why?
Neck
7
2018
97
0.670
Why?
Vascular Malformations
3
2010
105
0.620
Why?
Head
5
2018
72
0.590
Why?
Terminal Care
1
2018
37
0.540
Why?
Patients
1
2018
52
0.540
Why?
Flow Cytometry
7
2024
400
0.540
Why?
Hemangioma
3
2018
86
0.520
Why?
Attitude to Health
1
2018
193
0.510
Why?
Laryngectomy
3
2013
27
0.500
Why?
Laryngeal Neoplasms
2
2007
44
0.470
Why?
Carcinoma, Merkel Cell
4
2016
41
0.440
Why?
Quality of Life
3
2012
902
0.430
Why?
Laser Therapy
3
2011
75
0.430
Why?
Laryngeal Diseases
1
2013
12
0.390
Why?
Herpes Simplex
1
2013
25
0.380
Why?
Parotid Diseases
1
2012
3
0.380
Why?
Nuclear Proteins
6
2015
250
0.380
Why?
Neuromuscular Agents
1
2012
8
0.380
Why?
Botulinum Toxins, Type A
1
2012
15
0.380
Why?
Leukoplakia, Oral
1
2011
6
0.360
Why?
Aminolevulinic Acid
1
2011
9
0.360
Why?
Eating
1
2012
159
0.360
Why?
Lasers, Dye
1
2011
10
0.360
Why?
Photosensitizing Agents
1
2011
21
0.350
Why?
Photochemotherapy
1
2011
32
0.350
Why?
Survivors
1
2012
120
0.350
Why?
Photoacoustic Techniques
2
2024
24
0.340
Why?
Humans
49
2024
53230
0.330
Why?
Female
30
2024
28782
0.330
Why?
Neoplastic Cells, Circulating
4
2019
34
0.330
Why?
Middle Aged
21
2024
13419
0.320
Why?
Male
30
2024
27435
0.320
Why?
Cheek
1
2010
9
0.320
Why?
Pain
1
2012
351
0.320
Why?
Lip
1
2010
11
0.320
Why?
Facial Neoplasms
1
2010
22
0.310
Why?
Receptors, Progesterone
1
2009
68
0.300
Why?
Adult
21
2024
14534
0.300
Why?
Aged
16
2018
10429
0.290
Why?
Lymphatic Vessels
1
2009
45
0.290
Why?
Postoperative Complications
3
2012
1099
0.290
Why?
Skin Neoplasms
4
2016
500
0.290
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2004
1043
0.280
Why?
Surgical Flaps
1
2009
110
0.280
Why?
Neoplasms
1
2018
1334
0.280
Why?
Recurrent Laryngeal Nerve
1
2007
12
0.270
Why?
Laryngeal Nerves
1
2007
15
0.270
Why?
Melanoma
2
2022
277
0.270
Why?
Erythrocytes
2
2024
70
0.260
Why?
Factor VII
1
2007
3
0.260
Why?
Intracranial Arteriovenous Malformations
1
2007
33
0.260
Why?
Dilatation
2
2017
28
0.250
Why?
Malaria
2
2024
37
0.230
Why?
Adolescent
11
2024
6907
0.220
Why?
Gene Silencing
4
2009
122
0.220
Why?
Disease Models, Animal
3
2016
1517
0.220
Why?
Cell Proliferation
4
2016
1031
0.200
Why?
Melanoma, Experimental
2
2016
34
0.200
Why?
Immunohistochemistry
8
2014
975
0.190
Why?
Retrospective Studies
10
2015
6819
0.190
Why?
Promoter Regions, Genetic
7
2015
465
0.190
Why?
Xerostomia
1
2002
2
0.190
Why?
Treatment Outcome
7
2018
5595
0.190
Why?
Muscarinic Agonists
1
2002
10
0.190
Why?
Sjogren's Syndrome
1
2002
14
0.190
Why?
Plasmodium yoelii
1
2022
12
0.180
Why?
Endoscopy
2
2015
128
0.180
Why?
Thiophenes
1
2002
45
0.180
Why?
Nitric Oxide Synthase Type III
2
2013
83
0.180
Why?
Quinuclidines
1
2002
39
0.180
Why?
Transcription Factors
2
2015
571
0.170
Why?
Embolization, Therapeutic
3
2011
91
0.170
Why?
Veins
3
2010
74
0.170
Why?
Azepines
3
2016
21
0.170
Why?
Triazoles
3
2016
114
0.160
Why?
Child
10
2012
7379
0.150
Why?
Neoplasm Invasiveness
3
2010
281
0.150
Why?
Child, Preschool
8
2012
4162
0.150
Why?
Mast Cells
1
2018
56
0.140
Why?
Mice
10
2022
5982
0.140
Why?
Combined Modality Therapy
4
2018
640
0.140
Why?
Ki-67 Antigen
3
2013
57
0.140
Why?
Cricoid Cartilage
1
2017
10
0.130
Why?
Estradiol
1
2018
215
0.130
Why?
Mice, Nude
5
2016
232
0.130
Why?
Trachea
1
2017
55
0.130
Why?
Follow-Up Studies
3
2011
2318
0.130
Why?
Biopsy
3
2015
600
0.130
Why?
Lasers, Semiconductor
2
2022
7
0.120
Why?
Infant
7
2018
3805
0.120
Why?
Embolism
1
2016
18
0.120
Why?
Neoplasm Staging
2
2010
774
0.120
Why?
Benzoxazoles
1
2016
11
0.120
Why?
Matrix Metalloproteinase 2
1
2016
58
0.120
Why?
Matrix Metalloproteinase 9
1
2016
88
0.120
Why?
Qualitative Research
1
2018
384
0.120
Why?
Tracheotomy
1
2015
15
0.120
Why?
TOR Serine-Threonine Kinases
1
2016
83
0.120
Why?
Tracheal Stenosis
1
2015
14
0.120
Why?
Laryngostenosis
1
2015
12
0.120
Why?
Proto-Oncogene Proteins c-myb
1
2015
8
0.110
Why?
Aged, 80 and over
6
2015
3494
0.110
Why?
Larynx
2
2017
30
0.110
Why?
Pyrimidines
1
2016
205
0.110
Why?
Disease Progression
3
2014
880
0.110
Why?
Proto-Oncogene Proteins c-myc
1
2014
55
0.110
Why?
Fluorouracil
2
2004
59
0.110
Why?
Gene Expression Regulation, Neoplastic
3
2015
868
0.110
Why?
Carcinoma
2
2012
136
0.100
Why?
DNA Methylation
5
2009
592
0.100
Why?
Breast Neoplasms
2
2015
1222
0.100
Why?
Apoptosis
2
2016
1139
0.100
Why?
Plasmodium falciparum
2
2024
26
0.100
Why?
Animals
10
2022
13526
0.100
Why?
Mastication
1
2012
5
0.100
Why?
Trismus
1
2012
2
0.090
Why?
DNA, Neoplasm
2
2011
146
0.090
Why?
Cisplatin
2
2004
282
0.090
Why?
Radiotherapy, Adjuvant
1
2012
65
0.090
Why?
Receptors, Cell Surface
1
2013
109
0.090
Why?
Adaptor Proteins, Signal Transducing
3
2009
202
0.090
Why?
Recurrence
2
2011
694
0.090
Why?
Lymphangioma, Cystic
1
2011
9
0.090
Why?
Chemoradiotherapy
1
2012
50
0.090
Why?
Endothelium, Lymphatic
1
2011
8
0.090
Why?
Syndrome
1
2012
248
0.090
Why?
Cross-Sectional Studies
3
2024
1723
0.090
Why?
Antigens, CD
1
2013
217
0.090
Why?
Administration, Topical
1
2011
62
0.090
Why?
Microtubule-Associated Proteins
1
2011
61
0.090
Why?
Immunoenzyme Techniques
4
2016
134
0.090
Why?
Propranolol
1
2012
77
0.090
Why?
Epigenesis, Genetic
1
2015
412
0.090
Why?
Lymphatic Abnormalities
1
2011
23
0.090
Why?
Deglutition Disorders
1
2012
76
0.090
Why?
Enteral Nutrition
1
2012
157
0.090
Why?
Homeodomain Proteins
1
2011
81
0.090
Why?
Diagnosis, Differential
2
2011
1038
0.080
Why?
Tumor Suppressor Proteins
1
2011
130
0.080
Why?
Weight Gain
1
2012
245
0.080
Why?
Risk Assessment
1
2015
1368
0.080
Why?
Brain Neoplasms
1
2014
319
0.080
Why?
Xenograft Model Antitumor Assays
3
2016
228
0.080
Why?
Epigenomics
1
2011
76
0.080
Why?
Neoplasm Proteins
2
2003
330
0.080
Why?
Diagnostic Imaging
1
2011
176
0.080
Why?
Lip Neoplasms
1
2010
3
0.080
Why?
Neoplastic Stem Cells
1
2011
90
0.080
Why?
Neoplasm Recurrence, Local
2
2019
647
0.080
Why?
Hospitals, Teaching
1
2010
52
0.080
Why?
Neoadjuvant Therapy
1
2011
124
0.080
Why?
Survival Rate
3
2011
949
0.080
Why?
Lasers, Solid-State
1
2010
31
0.080
Why?
Medical Records
1
2010
85
0.080
Why?
Microsatellite Instability
1
2009
21
0.080
Why?
Vascular Surgical Procedures
1
2011
171
0.080
Why?
Melanins
1
2009
20
0.080
Why?
Mouth
1
2010
36
0.080
Why?
Multiple Endocrine Neoplasia Type 2a
1
2009
5
0.080
Why?
Carcinoma, Medullary
1
2009
12
0.080
Why?
Young Adult
3
2024
4511
0.080
Why?
Pilot Projects
1
2011
726
0.070
Why?
Proto-Oncogene Proteins c-ret
1
2009
33
0.070
Why?
Receptors, Estrogen
1
2009
134
0.070
Why?
Receptors, Vascular Endothelial Growth Factor
1
2008
26
0.070
Why?
Immunotherapy
1
2011
266
0.070
Why?
Muscle, Smooth, Vascular
1
2009
135
0.070
Why?
Port-Wine Stain
1
2008
14
0.070
Why?
Dose-Response Relationship, Drug
1
2011
1367
0.070
Why?
Blotting, Western
3
2016
587
0.070
Why?
Thyroid Neoplasms
1
2009
113
0.070
Why?
Vascular Endothelial Growth Factor A
1
2008
189
0.070
Why?
Cytokines
1
2011
627
0.070
Why?
Early Detection of Cancer
2
2022
190
0.070
Why?
Tumor Cells, Cultured
3
2016
441
0.070
Why?
Factor VIIa
1
2007
8
0.070
Why?
Jaw Diseases
1
2007
6
0.070
Why?
Practice Guidelines as Topic
1
2010
502
0.070
Why?
Infant, Newborn
2
2011
2913
0.060
Why?
Practice Management, Medical
1
2006
9
0.060
Why?
Osteonecrosis
1
2007
35
0.060
Why?
Postoperative Hemorrhage
1
2007
54
0.060
Why?
Tongue
1
2007
40
0.060
Why?
Bone Density Conservation Agents
1
2007
75
0.060
Why?
Diphosphonates
1
2007
92
0.060
Why?
Cell Line, Tumor
3
2015
1470
0.060
Why?
Otolaryngology
1
2006
62
0.060
Why?
Recombinant Proteins
1
2007
489
0.060
Why?
Prospective Studies
1
2011
2411
0.060
Why?
Skin
1
2008
419
0.060
Why?
Mice, Inbred NOD
2
2016
90
0.060
Why?
Mice, SCID
2
2016
180
0.060
Why?
Cameroon
1
2024
2
0.060
Why?
Hemeproteins
1
2024
4
0.060
Why?
Parasitemia
1
2024
6
0.060
Why?
Neoplasm Metastasis
2
2015
237
0.050
Why?
Malaria, Falciparum
1
2024
24
0.050
Why?
O(6)-Methylguanine-DNA Methyltransferase
1
2004
9
0.050
Why?
DNA Repair Enzymes
1
2004
44
0.050
Why?
Ataxia Telangiectasia
1
2004
7
0.050
Why?
Statistics, Nonparametric
1
2004
198
0.050
Why?
ROC Curve
1
2024
246
0.050
Why?
Polymerase Chain Reaction
4
2009
452
0.050
Why?
Genes, p16
1
2003
9
0.050
Why?
Lymph Node Excision
1
2004
132
0.050
Why?
Radiotherapy
1
2004
126
0.050
Why?
Magnetic Resonance Angiography
2
2018
72
0.050
Why?
Proteoglycans
1
2003
86
0.050
Why?
Magnetic Resonance Imaging
2
2007
1583
0.050
Why?
Antigens, Nuclear
2
2013
23
0.050
Why?
Transplantation, Heterologous
2
2013
78
0.050
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2016
579
0.050
Why?
Sensitivity and Specificity
1
2024
867
0.050
Why?
Membrane Glycoproteins
1
2003
238
0.050
Why?
Longitudinal Studies
1
2024
774
0.050
Why?
Double-Blind Method
1
2002
729
0.040
Why?
Survival Analysis
3
2009
659
0.040
Why?
Tryptases
1
2018
4
0.040
Why?
Estrogen Receptor beta
1
2018
54
0.040
Why?
Arkansas
1
2004
2068
0.030
Why?
Estrogen Receptor alpha
1
2018
85
0.030
Why?
Protein Transport
1
2018
168
0.030
Why?
Ultrasonography, Doppler
1
2018
42
0.030
Why?
Biopsy, Fine-Needle
2
2009
104
0.030
Why?
Cadaver
1
2017
90
0.030
Why?
Pressure
1
2017
102
0.030
Why?
Molecular Imaging
1
2016
28
0.030
Why?
Serum
1
2016
32
0.030
Why?
Risk Factors
3
2015
4017
0.030
Why?
Drug Synergism
1
2016
147
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2016
181
0.030
Why?
Jumonji Domain-Containing Histone Demethylases
1
2015
20
0.030
Why?
Acetylation
1
2015
97
0.030
Why?
Enhancer Elements, Genetic
1
2015
60
0.030
Why?
Keratin-20
1
2014
7
0.030
Why?
Mammography
1
2015
99
0.030
Why?
G1 Phase Cell Cycle Checkpoints
1
2014
18
0.030
Why?
Drug Therapy, Combination
1
2016
405
0.030
Why?
Prognosis
3
2004
2118
0.030
Why?
Chromatin
1
2015
145
0.030
Why?
Cell Cycle Proteins
1
2015
170
0.030
Why?
HEK293 Cells
1
2014
235
0.030
Why?
Gene Expression Regulation
1
2018
1003
0.030
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2013
38
0.030
Why?
Comorbidity
1
2015
638
0.020
Why?
Down-Regulation
1
2014
344
0.020
Why?
Protein Binding
1
2015
670
0.020
Why?
Actins
1
2013
114
0.020
Why?
RNA, Messenger
1
2016
1133
0.020
Why?
Base Sequence
2
2004
620
0.020
Why?
Lymphocele
1
2011
7
0.020
Why?
Tissue Survival
1
2011
10
0.020
Why?
Predictive Value of Tests
1
2014
934
0.020
Why?
Cell Line
1
2014
1016
0.020
Why?
Antibodies, Monoclonal, Murine-Derived
1
2011
46
0.020
Why?
Tissue Culture Techniques
1
2011
42
0.020
Why?
Neoplasms, Squamous Cell
1
2011
7
0.020
Why?
Gluconates
1
2011
1
0.020
Why?
Graft Survival
1
2011
157
0.020
Why?
Indomethacin
1
2011
36
0.020
Why?
Gene Expression Profiling
1
2016
1112
0.020
Why?
Injections, Subcutaneous
1
2011
55
0.020
Why?
Interleukin-2
1
2011
69
0.020
Why?
Carrier Proteins
2
2003
315
0.020
Why?
Time Factors
2
2007
2991
0.020
Why?
Interleukin-1beta
1
2011
88
0.020
Why?
Cyclophosphamide
1
2011
178
0.020
Why?
Interferon-gamma
1
2011
174
0.020
Why?
Drug Administration Schedule
1
2011
370
0.020
Why?
Disease-Free Survival
1
2011
466
0.020
Why?
Glottis
1
2010
34
0.020
Why?
Sclerotherapy
1
2010
47
0.020
Why?
Endothelial Cells
1
2011
289
0.020
Why?
Calcitonin
1
2009
30
0.020
Why?
Tumor Necrosis Factor-alpha
1
2011
392
0.020
Why?
Thyroidectomy
1
2009
61
0.020
Why?
Paraffin Embedding
1
2008
52
0.020
Why?
Mice, Transgenic
1
2009
561
0.020
Why?
Signal Transduction
1
2014
1748
0.020
Why?
Curettage
1
2007
12
0.020
Why?
Dental Care
1
2007
11
0.020
Why?
Mouth Floor
1
2007
5
0.020
Why?
Polyvinyl Alcohol
1
2007
11
0.020
Why?
Hyperbaric Oxygenation
1
2007
15
0.020
Why?
Collateral Circulation
1
2007
39
0.020
Why?
Current Procedural Terminology
1
2006
10
0.020
Why?
Insurance, Health, Reimbursement
1
2006
24
0.020
Why?
Cutaneous Fistula
1
2007
14
0.020
Why?
Pharyngeal Diseases
1
2007
16
0.020
Why?
Neck Dissection
1
2007
30
0.020
Why?
Angiography
1
2007
114
0.020
Why?
Office Visits
1
2006
45
0.020
Why?
Fistula
1
2007
26
0.020
Why?
Salvage Therapy
1
2007
138
0.020
Why?
Imidazoles
1
2007
114
0.020
Why?
Genetic Predisposition to Disease
1
2009
533
0.020
Why?
Adrenal Cortex Hormones
1
2007
116
0.010
Why?
Preoperative Care
1
2007
173
0.010
Why?
Ultrasonography
1
2006
426
0.010
Why?
United States
1
2015
5409
0.010
Why?
Guanine
1
2004
39
0.010
Why?
DNA Adducts
1
2004
79
0.010
Why?
Methylation
1
2004
127
0.010
Why?
Syndecans
1
2003
37
0.010
Why?
Syndecan-1
1
2003
73
0.010
Why?
Base Pair Mismatch
1
2003
20
0.010
Why?
Cell Count
1
2003
141
0.010
Why?
Antineoplastic Agents
1
2011
1232
0.010
Why?
Molecular Sequence Data
1
2003
759
0.010
Why?
DNA Repair
1
2003
197
0.010
Why?
Alcohol Drinking
1
2003
241
0.010
Why?
Anti-Bacterial Agents
1
2007
830
0.010
Why?
Smoking
1
2003
526
0.010
Why?
Multiple Myeloma
1
2007
3082
0.010
Why?
Suen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description